Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RUTA D RAO

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1831159441
CMS profile
415427
Location
CHICAGO, IL

General Payments · PY2018–2024

$336,471.06

  • Reported across 307 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$48,788.65

52 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
PFIZER INC. $18,124.91 14
Daiichi Sankyo Inc. $15,885.81 15
TerSera Therapeutics LLC $5,909.00 4
Acerta Pharma LLC $5,007.09 10
Genentech USA, Inc. $2,866.64 3
Lilly USA, LLC $625.00 1
Gilead Sciences, Inc. $146.31 3
Coherus Biosciences Inc. $142.27 1
Stemline Therapeutics Inc. $81.62 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $67,598.66 68
PY2019 $42,152.42 48
PY2020 $18,004.62 23
PY2021 $27,549.47 16
PY2022 $63,841.67 54
PY2023 $68,535.57 46
PY2024 $48,788.65 52

Payment records · PY2024 (52)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $82.92 01/31/2024 Food and Beverage Undisputed 01/23/2026 1104331772 CMS
AstraZeneca Pharmaceuticals LP $350.00 02/12/2024 Grant Undisputed 01/23/2026 1104495704 CMS
AstraZeneca Pharmaceuticals LP $74.80 08/01/2024 Food and Beverage Undisputed 01/23/2026 1105447285 CMS
AstraZeneca Pharmaceuticals LP $125.00 08/01/2024 Food and Beverage Undisputed 01/23/2026 1105789044 CMS
AstraZeneca Pharmaceuticals LP $2,055.00 08/14/2024 Consulting Fee Undisputed 01/23/2026 1104462264 CMS
AstraZeneca Pharmaceuticals LP $77.16 10/22/2024 Food and Beverage Undisputed 01/23/2026 1105764206 CMS
AstraZeneca Pharmaceuticals LP $92.21 10/29/2024 Food and Beverage Undisputed 01/23/2026 1104698192 CMS
AstraZeneca Pharmaceuticals LP $2,055.00 11/12/2024 Consulting Fee Undisputed 01/23/2026 1105497063 CMS
AstraZeneca Pharmaceuticals LP $57.69 12/11/2024 Food and Beverage Undisputed 01/23/2026 1104343710 CMS
AstraZeneca Pharmaceuticals LP $37.31 12/12/2024 Food and Beverage Undisputed 01/23/2026 1105524557 CMS
Coherus Biosciences Inc. $142.27 06/01/2024 Food and Beverage Undisputed 01/23/2026 1147277568 CMS
Daiichi Sankyo Inc. $13.12 01/17/2024 Food and Beverage Undisputed 01/23/2026 1089472569 CMS
Daiichi Sankyo Inc. $405.55 03/08/2024 Travel and Lodging Undisputed 01/23/2026 1089472547 CMS
Daiichi Sankyo Inc. $3,425.00 04/10/2024 Consulting Fee Undisputed 01/23/2026 1089472535 CMS
Daiichi Sankyo Inc. $342.50 04/10/2024 Consulting Fee Undisputed 01/23/2026 1089472549 CMS
Daiichi Sankyo Inc. $685.00 04/10/2024 Consulting Fee Undisputed 01/23/2026 1089472555 CMS
Daiichi Sankyo Inc. $890.50 05/29/2024 Consulting Fee Undisputed 01/23/2026 1089472533 CMS
Daiichi Sankyo Inc. $1,370.00 05/29/2024 Consulting Fee Undisputed 01/23/2026 1089472537 CMS
Daiichi Sankyo Inc. $685.00 05/29/2024 Consulting Fee Undisputed 01/23/2026 1089472543 CMS
Daiichi Sankyo Inc. $21.98 06/12/2024 Travel and Lodging Undisputed 01/23/2026 1089472545 CMS
Daiichi Sankyo Inc. $66.00 06/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1089472553 CMS
Daiichi Sankyo Inc. $103.66 06/12/2024 Food and Beverage Undisputed 01/23/2026 1089472557 CMS
Daiichi Sankyo Inc. $1,712.50 07/24/2024 Consulting Fee Undisputed 01/23/2026 1089472551 CMS
Daiichi Sankyo Inc. $2,740.00 08/14/2024 Consulting Fee Undisputed 01/23/2026 1089472539 CMS
Daiichi Sankyo Inc. $1,712.50 10/09/2024 Consulting Fee Undisputed 01/23/2026 1089472541 CMS
Daiichi Sankyo Inc. $1,712.50 10/16/2024 Consulting Fee Undisputed 01/23/2026 1089472559 CMS
Genentech USA, Inc. $228.46 12/10/2024 Food and Beverage Undisputed 01/23/2026 1133103032 CMS
Genentech USA, Inc. $2,280.00 12/10/2024 Consulting Fee Undisputed 01/23/2026 1133103036 CMS
Genentech USA, Inc. $358.18 12/10/2024 Travel and Lodging Undisputed 01/23/2026 1133103040 CMS
Gilead Sciences, Inc. $45.75 06/03/2024 Food and Beverage Undisputed 01/23/2026 1133832039 CMS
Gilead Sciences, Inc. $56.27 09/15/2024 Food and Beverage Undisputed 01/23/2026 1133832041 CMS
Gilead Sciences, Inc. $44.29 12/11/2024 Food and Beverage Undisputed 01/23/2026 1133832043 CMS
Lilly USA, LLC $625.00 12/17/2024 Consulting Fee Undisputed 01/23/2026 1135359654 CMS
PFIZER INC. $4,000.00 01/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1132041011 CMS
PFIZER INC. $1,262.00 01/03/2024 Consulting Fee Undisputed 01/23/2026 1132041013 CMS
PFIZER INC. $678.99 03/14/2024 Travel and Lodging Undisputed 01/23/2026 1131737702 CMS
PFIZER INC. $190.03 03/14/2024 Travel and Lodging Undisputed 01/23/2026 1131737704 CMS
PFIZER INC. $446.40 03/14/2024 Travel and Lodging Undisputed 01/23/2026 1131737706 CMS
PFIZER INC. $5,375.00 03/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131910856 CMS
PFIZER INC. $94.70 03/25/2024 Travel and Lodging Undisputed 01/23/2026 1131907966 CMS
PFIZER INC. $145.14 05/31/2024 Food and Beverage Undisputed 01/23/2026 1131481796 CMS
PFIZER INC. $48.51 06/01/2024 Food and Beverage Undisputed 01/23/2026 1131328479 CMS
PFIZER INC. $86.66 06/01/2024 Food and Beverage Undisputed 01/23/2026 1131622623 CMS
PFIZER INC. $4,250.00 06/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131482725 CMS
PFIZER INC. $97.07 07/26/2024 Food and Beverage Undisputed 01/23/2026 1131833966 CMS
PFIZER INC. $1,262.00 08/01/2024 Honoraria Undisputed 01/23/2026 1131623595 CMS
PFIZER INC. $188.41 09/13/2024 Food and Beverage Undisputed 01/23/2026 1131622627 CMS
Stemline Therapeutics Inc. $81.62 06/02/2024 Food and Beverage Undisputed 01/23/2026 1142963706 CMS
TerSera Therapeutics LLC $3,773.00 09/05/2024 Consulting Fee Undisputed 01/23/2026 1144718076 CMS
TerSera Therapeutics LLC $95.00 10/23/2024 Food and Beverage Undisputed 01/23/2026 1144718078 CMS
TerSera Therapeutics LLC $41.00 10/23/2024 Travel and Lodging Undisputed 01/23/2026 1144718080 CMS
TerSera Therapeutics LLC $2,000.00 10/23/2024 Consulting Fee Undisputed 01/23/2026 1144718082 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.